Proteomics: Technologies and Global Markets
- The global market for proteomics is expected to increase from $6.7 billion in 2008 to an estimated $7.9 billion in 2009 and $19.4 billion in 2014, for a compound annual growth rate (CAGR) of 19.7%.
- Proteomics equipment was valued at $4.1 billion in 2008 and an estimated $4.8 billion in 2009. This is expected to increase to $13.0 billion in 2014, for a CAGR of 22%..
- Proteomics technologies were worth $1.3 billion in 2008 and an estimated $1.5 billion in 2009. This segment is expected to increase at a CAGR of 13.9% to reach $2.9 billion in 2014.
STUDY GOALS AND OBJECTIVES
- To define global proteomics market and other aligned markets, technologies, and terms.
- To measure the global proteomics market with respect to technologies, equipment, services, database, and software and applications.
- To analyze intensively the market structure with respect to drivers, inhibitors, and challenges influencing the market growth.
- To identify the trends, gaps, and opportunities in each of the micro-markets.
- To analyze and forecast the revenues of market segments with respect to geographies (North America, Europe, Asia, and the rest of the world or ROW).
- To strategically profile and analyze the market players and their core competencies in the field of proteomics for each of its market segment.
- In-depth analysis of competitive scenario, top-selling products, and services of the proteomics market.
- To track and analyze recent developments, alliances, joint ventures, mergers, and acquisitions of the market players in the industry.
- Technologies (based on kinds of proteomics, process and component and applications)
- Database and software market (proteomics database, software, laboratory software programs)
- Equipment market (2-D electrophoresis or 2-DE, chromatography systems, mass spectrometry, microfluidic (MF) chip technology and systems, microsphere analysis components, proteomics systems, protein microarrays, and others).
- Applications market (scientific and clinical applications, and others, including homeland security and personalized medicines)
- Services market (laboratory services, database analysis and maintenance, and others)
- Proteomics technology providers
- Proteomics equipment manufacturers and dealers
- Proteomics laboratory service providers
- Proteomics database and software providers
- Biopharmaceutical (drug design and discovery) companies
- Proteomics research companies and institutes
- Proteomics associations
- Global weight management market
- Tele-medicines – a mainstream technology
- High-growth markets in healthcare and life sciences
- Carbonated soft drinks market
- Adoption rates and analysis of OTC diabetic medicines and supplements
- Radio Frequency Identification (RFID), Real Time Locating Systems (RTLS), IP surveillance, and other emerging technologies in the healthcare domain.
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers
Proteomics is an emerging field that has developed in the wake of genomics. Its goal is to understand protein expression at the cellular level, and apply this information to scientific and medical problems. For example, compared to healthy cells, how does influenza virus infection affect the total protein output? Are any of the proteins expressed only in the infected cells suitable targets for new antiviral drugs? This approach also applies to cancerous cells, and cells from patients with degenerative diseases and many other conditions. New technologies like protein chips and capillary electrophoresis are emerging to serve proteomic studies, and more mature technologies like 2-D electrophoresis, mass spectroscopy, and nuclear magnetic resonance spectroscopy are being adapted for protein studies, and in some cases, for high throughput uses. Bioinformatics applications are constantly being developed to analyze the data produced by all of these technologies.
This BCC study examines how proteomics technologies have affected basic research and pharmaceutical research, and how they are likely to affect research in the near future. It also analyzes how proteomics technologies are developing, and examines new companies that are likely to make substantial contributions to the field. An important part of the report analyzes instruments that are vital to proteomics studies. Sales and spending projections through 2006 are included.